Sonova Holding (OTCMKTS:SONVY) Receives Consensus Recommendation of “Hold” from Analysts

Shares of Sonova Holding (OTCMKTS:SONVY) have been assigned an average rating of “Hold” from the nine brokerages that are currently covering the firm, MarketBeat Ratings reports. Three research analysts have rated the stock with a sell recommendation, four have assigned a hold recommendation, one has given a buy recommendation and one has issued a strong buy recommendation on the company.

A number of equities analysts have recently weighed in on SONVY shares. Zacks Research lowered shares of Sonova from a “hold” rating to a “strong sell” rating in a research report on Tuesday, December 9th. Rothschild Redb raised shares of Sonova from a “strong sell” rating to a “hold” rating in a research note on Monday, October 6th. Royal Bank Of Canada upgraded Sonova to a “moderate buy” rating in a report on Tuesday, November 18th. Finally, BNP Paribas Exane initiated coverage on Sonova in a research note on Monday, October 20th. They set an “underperform” rating on the stock.

Sonova Trading Down 1.4%

Shares of SONVY stock opened at $53.87 on Thursday. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.24 and a quick ratio of 0.91. The firm has a 50-day moving average price of $52.46 and a 200 day moving average price of $54.70. Sonova has a twelve month low of $47.55 and a twelve month high of $69.24.

Sonova Company Profile

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.